These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20718634)

  • 1. G protein-coupled receptor oligomerization for what?
    Ciruela F; Vallano A; Arnau JM; Sánchez S; Borroto-Escuela DO; Agnati LF; Fuxe K; Fernández-Dueñas V
    J Recept Signal Transduct Res; 2010 Oct; 30(5):322-30. PubMed ID: 20718634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions.
    Fuxe K; Marcellino D; Borroto-Escuela DO; Frankowska M; Ferraro L; Guidolin D; Ciruela F; Agnati LF
    J Recept Signal Transduct Res; 2010 Oct; 30(5):272-83. PubMed ID: 20684666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled receptor oligomerization and brain integration: focus on adenosinergic transmission.
    Ciruela F; Fernández-Dueñas V; Llorente J; Borroto-Escuela D; Cuffí ML; Carbonell L; Sánchez S; Agnati LF; Fuxe K; Tasca CI
    Brain Res; 2012 Oct; 1476():86-95. PubMed ID: 22575562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.
    Breitwieser GE
    Circ Res; 2004 Jan; 94(1):17-27. PubMed ID: 14715532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.
    Tilakaratne N; Sexton PM
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):979-87. PubMed ID: 16405456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration.
    Borroto-Escuela DO; Tarakanov AO; Guidolin D; Ciruela F; Agnati LF; Fuxe K
    IUBMB Life; 2011 Jul; 63(7):463-72. PubMed ID: 21698749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using quantitative BRET to assess G protein-coupled receptor homo- and heterodimerization.
    Achour L; Kamal M; Jockers R; Marullo S
    Methods Mol Biol; 2011; 756():183-200. PubMed ID: 21870226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluorescence studies of G-protein coupled receptors oligomerization].
    Grymek K; Gaska M; Łukasiewicz S; Górecki A; Dziedzicka-Wasylewska M
    Postepy Biochem; 2008; 54(4):431-7. PubMed ID: 19248590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.
    Gilchrist A
    Trends Pharmacol Sci; 2007 Aug; 28(8):431-7. PubMed ID: 17644194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional crosstalk between GPCRs: with or without oligomerization.
    Prezeau L; Rives ML; Comps-Agrar L; Maurel D; Kniazeff J; Pin JP
    Curr Opin Pharmacol; 2010 Feb; 10(1):6-13. PubMed ID: 19962942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.
    Cottet M; Albizu L; Perkovska S; Jean-Alphonse F; Rahmeh R; Orcel H; Méjean C; Granier S; Mendre C; Mouillac B; Durroux T
    Curr Opin Pharmacol; 2010 Feb; 10(1):59-66. PubMed ID: 19896898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetry of GPCR oligomers supports their functional relevance.
    Maurice P; Kamal M; Jockers R
    Trends Pharmacol Sci; 2011 Sep; 32(9):514-20. PubMed ID: 21715028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics and molecular modelling approaches to GPCR oligomerization.
    Simpson LM; Taddese B; Wall ID; Reynolds CA
    Curr Opin Pharmacol; 2010 Feb; 10(1):30-7. PubMed ID: 20015686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRIP: a server for predicting interfaces for GPCR oligomerization.
    Nemoto W; Fukui K; Toh H
    J Recept Signal Transduct Res; 2009 Dec; 29(6):312-7. PubMed ID: 19888901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time resolved FRET strategy with fluorescent ligands to analyze receptor interactions in native tissues: application to GPCR oligomerization.
    Cottet M; Albizu L; Comps-Agrar L; Trinquet E; Pin JP; Mouillac B; Durroux T
    Methods Mol Biol; 2011; 746():373-87. PubMed ID: 21607869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dynamics of GPCR Oligomerization and Their Functional Consequences.
    Sleno R; Hébert TE
    Int Rev Cell Mol Biol; 2018; 338():141-171. PubMed ID: 29699691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensing G protein-coupled receptor activation.
    Ambrosio M; Zürn A; Lohse MJ
    Neuropharmacology; 2011 Jan; 60(1):45-51. PubMed ID: 20727363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain.
    Ciruela F; Gómez-Soler M; Guidolin D; Borroto-Escuela DO; Agnati LF; Fuxe K; Fernández-Dueñas V
    Biochim Biophys Acta; 2011 May; 1808(5):1245-55. PubMed ID: 21316336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.